Searched for
DRUG PRICES COMPARISON
Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...- Stock picks of the week; 5 stocks with consistent score improvement and upside potential of up to 25%Even in normal times it is futile to try and guess the outcome of most global events. But in the New World Order, it makes no sense at all ...
- US drugs site TrumpRx to list 600 generics as Donald Trump targets lower pricesPresident Donald Trump is expanding access to affordable medicines. The government website TrumpRx.gov will now list over 600 generic drugs...
- Profit on paper, loss in reality: How a routine accounting tool is used to deceive and take investors for a rideAmortisation is a number most investors skip, but it can shape reported profit. On the surface, it looks routine: A company spreads the cos...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...
- GLP-1 impact: Jefferies sees these 3 stocks as winners in the race for Ozempic, Wegovy genericsIndian drug makers are launching affordable generic Semaglutide, the active ingredient in popular weight-loss drugs. Sun Pharma, Lupin, and...
- Weight is over! Pharma stocks jump up to 4% as patent for Ozempic's key ingredient expires; what lies ahead?Pharma stocks rose up to 4% as Novo Nordisk’s semaglutide patent nears expiry, raising expectations of cheaper generics in India. Strong gr...
- Trump says he's cut drug prices by up to 1,500%. That's not possibleDonald Trump claimed significant drug price cuts, even up to 1500%. Experts refute this, stating such cuts are impossible. They suggest it ...
- Trump pushes 'Most Favoured Nation' plan to slash US drug prices, defends tariff policyPresident Trump announced his plan to lower prescription drug prices in the US through the "Most Favoured Nation" pricing model, aiming to ...
- Donald Trump's pharma pricing diktat details and how it can be legally challengedPresident Trump signed an executive order aimed at lowering U.S. drug prices to match those of other countries, prompting industry concerns...
- What is Trump's ‘most favored nation’ drug pricing policy and how will it reduce costs? ExplainedPresident Donald Trump on Sunday announced that he will be signing an executive order to reduce prescription drug prices in the US. The 78-...
- Could a new policy change the way Americans pay for drugs forever? Trump's new plan revealedThe Trump administration is exploring a policy to link US drug prices to those of other developed nations. This move is causing concern in ...
- Drugmakers offer Canada C$1 billion to scrap some pending pricing rulesThe government has argued that Canada's patented drug prices are too high, trailing only the United States and Switzerland, and that other ...
- New treatment to be made affordable for patients: TB AlliancePretomanid is the third TB drug to have been approved by the USFDA in the last 40 years.
- Cost effect: Stents costing Rs 40,000 sold to you at Rs 1.2 lakhThe dealer price or the landed cost in India for a drug eluting stent (DES) is not more than Rs 40,000, often just Rs 20,000.
- Department of Pharmaceuticals considering price monitoring cellsA scheme of National Pharmaceutical Pricing Authority for setting up price monitoring cell in states" is under initial scrutiny of the Depa...
- AIOCD for drug pricing on median price with over 1% mkt shareWelcoming the government's draft proposal on drug pricing policy, the chemist body said the Centre should also decide the weighted average ...
- Promotional expenses of pharma cos to be cappedThe government is all set to cap the promotional expenses of pharmaceutical companies and limit the price at which new brands are launched ...
- NPPA has no tool to monitor prices real timeTill early this January, drug price regulator NPPA could force five leading drug makers to cut prices of 11 popular medicines upto a maximu...
Load More
